SCHEMBL18357145

SCHEMBL18357145

CC(C)(O)c1c(Cl)cccc1-c1cccc2c1oc1ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.49
▸ MEN1 O00255 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ GGPS1 O95749 1/20 0.41
▸ AHR P35869 4/20 0.41
▸ PRKDC P78527 3/20 0.39
▸ PIK3CD O00329 1/20 0.39
▸ PIK3CB P42338 1/20 0.39
▸ NMUR2 Q9GZQ4 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ CSNK2A2 P19784 1/20 0.37
▸ CSNK2B P67870 1/20 0.37
▸ PIM3 Q86V86 1/20 0.37
▸ PIM2 Q9P1W9 1/20 0.37
▸ CCNC P24863 1/20 0.36
▸ CDK8 P49336 1/20 0.36
▸ MAOA P21397 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21971522 0.81 ALOX5 (0.54) ALOX5MEN1CYP2C19KMT2AGGPS1
SCHEMBL21037626 0.80 ALOX5 (0.57) ALOX5MEN1KMT2AGGPS1AHR
SCHEMBL4554342 0.80 ALOX5 (0.54) ALOX5MEN1CYP2C19KMT2AGGPS1
SCHEMBL22129979 0.79 ALOX5 (0.55) ALOX5GGPS1AHRPRKDCPIK3CD
SCHEMBL20205297 0.78 ALOX5 (0.56) ALOX5MEN1CYP2C19KMT2AGGPS1
SCHEMBL4554355 0.77 ALOX5 (0.52) ALOX5MEN1CYP2C19KMT2AGGPS1
SCHEMBL16745228 0.77 ALOX5 (0.49) ALOX5MEN1CYP2C19KMT2AGGPS1
SCHEMBL23058704 0.77 ALOX5 (0.54) ALOX5MEN1KMT2AGGPS1AHR
SCHEMBL23634669 0.77 ALOX5 (0.48) ALOX5MEN1CYP2C19KMT2AGGPS1
SCHEMBL10945864 0.76 ALOX5 (0.68) ALOX5MEN1CYP2C19KMT2AGGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170005274-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2017-01-05 — — US disclosed
US-20170005274-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2017-01-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170005274-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC EQUIPMENT LEF1, RPL6, OR10J3 ALOX5 1352/4885MEN1 1124/4885CYP2C19 2063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback